Abstract
Background
Hypocalcemia is the most common complication after parathyroidectomy, contributing to extended hospital stays and higher hospitalization costs. The present study aimed to evaluate whether preoperative Calcitriol could help reduce hypocalcemia rates.
Method
In this randomized controlled trial, we included 80 patients with primary hyperparathyroidism candidates for parathyroidectomy. The intervention group received Calcitriol 0.25 µg/day 1 week before parathyroidectomy. Baseline laboratory data, parathyroid hormone level (before, during, after 5, and 10 min of operation), calcium level (6, 24, and 48 h after operation), and clinical signs and symptoms were recorded.
Results
Of the 80 participants, 40 (mean age: 53.36 ± 12.97) were randomized to the intervention, and 40 (mean age: 52.84 ± 12.32) to the control group. There were no statistically significant differences in age, tumor size, gender, baseline laboratory data, intra-operative PTH, and calcium level 6 and 24 h after the operation. We observed a significantly higher calcium level in the intervention group 48 h post-operation (8.57 ± 0.30 vs. 8.33 ± 0.38). Also, days of hospital stay and symptomatic hypocalcemia rate were significantly lower in the intervention group.
Conclusion
In patients with primary hyperparathyroidism, preoperative Calcitriol may be of value in preventing post-parathyroidectomy hypocalcemia and subsequent complications.
Similar content being viewed by others
Availability of data and materials
SPSS data of the participants can be requested from the authors. Please write to the corresponding author if you are interested in such data.
Abbreviations
- PTH:
-
Parathyroid hormone
- PTX:
-
Parathyroidectomy
References
Ellul D, Townsley RB, Clark LJ (2013) Does the pre-operative serum phosphate level predict early hypocalcaemia following parathyroidectomy for primary hyperparathyroidism? Surgeon 11(3):125–129
Loewe A, Lutz Y, Nairn D, Fabbri A, Nagy N, Toth N et al (2019) Hypocalcemia-induced slowing of human sinus node pacemaking. Biophys J 117(12):2244–2254
Westerdahl J, Lindblom P, Valdemarsson S, Tibblin S, Bergenfelz A (2000) Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 135(2):142–147
Witteveen JE, van Thiel S, Romijn JA, Hamdy NA (2013) Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 168(3):R45-53
McLeod IK, Arciero C, Noordzij JP, Stojadinovic A, Peoples G, Melder PC et al (2006) The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid 16(3):259–265
Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84(4):654–660
Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70(2):114–119 (discussion 9–20)
Crea N, Pata G, Casella C, Cappelli C, Salerni B (2012) Predictive factors for postoperative severe hypocalcaemia after parathyroidectomy for primary hyperparathyroidism. Am Surg 78(3):352–358
Sinha S, Fok M, Ahmad I, Al-Sheikh M, Backhouse C (2020) Shortening postoperative stay after parathyroidectomy–a district general hospital experience. Int Arch Otorhinolaryngol 24(3):e313–e318
Ho LY, Wong PN, Sin HK, Wong YY, Lo KC, Chan SF et al (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18(1):12
Cheng SP, Liu CL, Chen HH, Lee JJ, Liu TP, Yang TL (2009) Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg 33(1):72–79
Gao D, Lou Y, Cui Y, Liu S, Cui W, Sun G (2022) Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis. Ren Fail 44(1):503–512
Sun X, Zhang X, Lu Y, Zhang L, Yang M (2018) Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Sci Rep 8(1):7743
Heath D, Van’t Hoff W, Barnes A, Gray J (1979) Value of 1-alpha-hydroxy vitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy. Br Med J 1(6161):450–452
Niramitmahapanya S, Sunthornthepvarakul T, Deerochanawong C, Sarinnapakorn V, Athipan P (2011) Role of loading calcitriol to control hypocalcemia after parathyroidectomy in chronic kidney disease. J Med Assoc Thai 94(3):295–302
Alsafran S, Sherman SK, Dahdaleh FS, Ruhle B, Mercier F, Kaplan EL et al (2019) Preoperative calcitriol reduces postoperative intravenous calcium requirements and length of stay in parathyroidectomy for renal-origin hyperparathyroidism. Surgery 165(1):151–157
Corea N (2007) Calcitriol. In: Enna SJ, Bylund DB (eds) xPharm: the comprehensive pharmacology reference. Elsevier, New York, pp 1–5
Clair F, Leenhardt L, Bourdeau A, Zingraff J, Robert D, Dubost C et al (1987) Effect of calcitriol in the control of plasma calcium after parathyroidectomy. A placebo-controlled, double-blind study in chronic hemodialysis patients. Nephron 46(1):18–22
Ferreira D, Vilayur E, Gao M, Sankoorikal C, Bendinelli C (2019) Calcitriol loading before total parathyroidectomy with autotransplant in patients with end-stage kidney disease: does it prevent postoperative hypocalcaemia? Intern Med J 49(7):886–893
Parnell KE, Oltmann SC (2018) The surgical management of primary hyperparathyroidism: an updated review. Int J Endocr Oncol 5(1):IJE07
Steinl GK, Kuo JH (2021) Surgical Management of secondary hyperparathyroidism. Kidney Int Rep 6(2):254–264
Norman JG, Politz DE (2007) Safety of immediate discharge after parathyroidectomy: a prospective study of 3,000 consecutive patients. Endocr Pract 13(2):105–113
Rajeev P, Sutaria R, Ezzat T, Mihai R, Sadler GP (2014) Changing trends in thyroid and parathyroid surgery over the decade: is same-day discharge feasible in the United Kingdom? World J Surg 38(11):2825–2830
Peel JK, Melck AL (2016) Same-day discharge after unilateral parathyroidectomy is safe. Can J Surg 59(4):242–246
Meyer SK, Zorn M, Frank-Raue K, Buchler MW, Nawroth P, Weber T (2009) Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism. Eur J Endocrinol 160(2):275–281
Adler JT, Sippel RS, Chen H (2010) 25-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism. Ann Surg Oncol 17(11):2958–2962
Mattoo S, Agarwal A, Mayilvaganan S, Mishra P, Agarwal G, Mishra A et al (2021) Role of postoperative intact serum PTH as an early predictor of severe post-thyroidectomy hypocalcemia: a prospective study. J Endocrinol Invest 44(9):1961–1970
Lacroix C, Potard G, Thuillier P, Le Pennec R, Prévot J, Roudaut N et al (2022) Use of the parathyroid hormone assay at H6 post thyroidectomy: an early predictor of hypocalcemia. J Endocrinol Invest 45(1):1–8
Pastoricchio M, Bernardi S, Bortul M, de Manzini N, Dobrinja C (2022) Autofluorescence of parathyroid glands during endocrine surgery with minimally invasive technique. J Endocrinol Invest 45(7):1393–1403
Nasiri S, Meshkati Yazd S, Kamran H, Kahrizi M, Azhdari M, Shahriarirad R (2022) Autotransplantation of parathyroid tissue into subcutaneous subclavicular area following total parathyroidectomy in secondary hyperparathyroidism. J Endocrinol Invest. https://doi.org/10.1007/s40618-022-01864-w
Randle RW, Balentine CJ, Wendt E, Schneider DF, Chen H, Sippel RS (2016) Should vitamin D deficiency be corrected before parathyroidectomy? J Surg Res 204(1):94–100
Redman C, Bodenner D, Stack B Jr (2009) Role of vitamin D deficiency in continued hyperparathyroidism following parathyroidectomy. Head Neck 31(9):1164–1167
Sava L, Pillai S, More U, Sontakke A (2005) Serum calcium measurement: total versus free (ionized) calcium. Indian J Clin Biochem 20(2):158–161
Funding
The study was financially supported by the office of vice-chancellor for research at Tehran University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
SN, SMMY, and RS designed the study. NM collected the data while RS performed the statistical analysis. RS, AA, and AMA drafted the manuscript. RS, SN and SMMY revised the manuscript. All authors proofread the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have not disclosed any competing interests.
Ethical approval and consent to participate
Tehran University of Medical Sciences Human Ethics Committee approved the study (IR.TUMS.MEDICINE.REC.1396.3403). This study was registered in the Iranian registry of clinical trials (Trial number: IRCT20220822055773N2). Written informed consent form was obtained from all the participants enrolled in this trial. All patients’ information was de-identified and documented confidentially, and patients were able to exit any time during the trial if they desired. All ethical principles of the Declaration of Helsinki were considered in this trial.
Consent to publication
Not applicable.
Informed consent
All participants provided informed consent prior to their participation.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shahriarirad, R., Meshkati Yazd, S.M., Ardekani, A. et al. Calcitriol supplementation before parathyroidectomy and calcium level after surgery in parathyroid adenoma patients: a randomized controlled trial. J Endocrinol Invest 46, 985–990 (2023). https://doi.org/10.1007/s40618-022-01963-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-022-01963-8